India’s Zydus Lifesciences posts lower profit as expenses outpace revenue growth

Nov 4 (Reuters) – Indian drugmaker Zydus Lifesciences reported a 26.6% fall in second-quarter profit on Wednesday, as rising expenses outweighed stronger demand, pushing its shares about 4% lower. Consolidated net profit fell to 9.26 billion rupees ($97.77 million) for the July-September quarter from 12.61 billion rupees a year earlier. Here are more details: • Total revenue rose 29.2%…

India’s Alembic Pharma profit jumps on strong US sales — Salem Radio Network News · Right
India’s Zydus Lifesciences posts lower profit as expenses outpace revenue growth — Salem Radio Network News · Right
India’s Alembic Pharma profit jumps on strong US sales — WTVB - Coldwater
Zydus Lifesciences Q2 results: Net profit falls 26.6% to ₹925.5 crore — Business Standard — Companies
India’s Zydus Lifesciences posts lower profit as expenses outpace revenue growth — WNCY - 100.3 FM - Green Bay

Open True Mainstream to compare left, right, and center coverage